entertainment -WSS

entertainment

author：entertainment 2025-09-28 21:05:31 - browse：27787

A collage illustration with a patient in the center with a hand to the left administering treatment and a doctor in the background. -- health tech coverage from STAT — Katy Lemay for STAT

The makers of minimally invasive surgical devices seemed poised to capture a wide swath of the obesity treatment market. Patients needed an option that lay between the two treatment extremes: cutting open the abdomen to perform permanent bariatric surgery, or changing your diet or exercise routine.

Then, a new class of weight loss medications that successfully mimic the feeling of fullness hit the market, and the landscape changed.

“It turns out that what came along — before those endoscopic devices have really matured — is these new drugs,” said Lee Kaplan, director of Massachusetts General’s obesity institute. Since the Food and Drug Administration approved Novo Nordisk’s Wegovy in 2021, it and similar drugs that followed have swiftly captured the public’s interest — and are on their way to generating billions of dollars in sales.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

focus

WSS

Brain technologies pose threats that are all too real, experts warn

STAT reporters are Pulitzer Prize finalists for investigative reporting

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

As billionaires fund anti

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

hotspot

entertainment

entertainment

Alkermes shareholders re

Fertility clinic egg and embryo storage is a disaster

Tori Bowie and the unacceptable rates of Black maternal death

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

Activists slam private health insurers over coverage restrictions

AltruBio raises $225 million to develop ulcerative colitis drug

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Warren pushes Witty on UnitedHealth's control over physicians

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

As billionaires fund anti

hotspot

Brain MRIs reveal impact of 'toxic stress' on Black children

The creative science of coining drug names

The White House hikes tariffs on plastic syringes made in China

Galapagos to make CAR

Black vets could get higher VA benefits if race not used in lung test

Deliver public health messages at the right time

focus

focus

focus

explore